NeoProfen (ibuprofen lysine) Injection: Recall and Shortage – Risk of Particulate Matter

Audience: Cardiovascular Surgery, Anesthesia, Pharmacy
ISSUE: FDA notified healthcare professionals of a recall of two lots of NeoProfen (ibuprofen lysine) Injection because the product failed to meet a visible particulate quality requirement….

No related posts.

FREE Case Review

Defective DrugsAdverse reactions to medications on the market.

Personal InjuryPersonal injuries resulting from negligence may lead to significant medical expenses.

Toxic ExposureDangerous toxins linked to cancers, birth defects, and chronic respiratory problems.

DiseasesDangerous toxins linked to cancers, birth defects, and chronic respiratory problems.

Financial FraudsUnethical actions by large corporations may cause financial hardship.

Medical MalpracticeMedical errors or negligent health care resulting in injury or death.

NeoProfen (ibuprofen lysine) Injection: Recall and Shortage – Risk of Particulate Matter

FREE Case Review

Trending Topics